223
Participants
Start Date
December 31, 2011
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Lyrica (pregabalin)
Capsule, 300 mg/d, BID, 8 weeks treatment
Placebo
Capsule, 300 mg/d, BID, 8 weeks treatment
Peking University First Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University/Department of Internal Neurology, Beijing
Peking University Third Hospital, Neurology Department, Beijing
Neurology Department, Beijing Hospital of the Ministry of Health, Beijing
Neurology Department, Shanghai Changzheng Hospital, Shanghai
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
Huashan Hospital, Fudan University/Neurology Department, Shanghai
Renji Hospital Shanghai Jiao Tong University School of Medicine/Neurology Department, Shanghai
Neurology Department, Jiangsu Province Hospital, Nanjing
The Second Affiliated Hospital of Soochow University/Neurology Department, Suzhou
Qilu Hospital of Shandong University, Jinan
Tianjin Medical University General Hospital, Dermatological Department, Tianjin
The First Affiliated Hospital of College of Medicine, Zhejiang University/Dermatology and STD Dept., Hangzhou
Sir Run Run Shaw Hospital Affiliated of College of Medicine, Zhejiang University/Neurology Dept., Hangzhou
the first affiliated hospital ,chongqing medical university, Department of Neurology, Chongqing
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
GuangZhou First Municipal People's Hospital, Guangzhou
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
Shenzhen People's Hospital, Shenzhen
West China Hospital of Sichuan University, Neurology Department, Chengdu/wuhou D
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY